Nabil A. Mohsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nabil A. Mohsen has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Fatma El Mougy
Department of Clinical and Chemical Pathology, Kasr Al-Ainy Medical School, Cairo University, Egypt
1 shared publication - Hala Abdullatif
Department of Pediatrics, Kasr Alainy Medical School, Cairo University, Cairo, Egypt
1 shared publication - Hanaa El-Karaksy
Department of Pediatrics, Cairo University, Cairo, Egypt
1 shared publication - Hanaa Mostafa El-Karaksy
Department of Pediatrics, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt -
1 shared publication - Mona E. Fahmy
Research Institute of Ophthalmology
1 shared publication - Mortada El-Shabrawi
Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt
1 shared publication
Latest Publications
- 1 June 2016
- Published by Elsevier in Arab Journal of Gastroenterology
- Vol. 17 (2) , 105-109
Haemophagocytic lymphohistiocytosis presenting as neonatal liver failure: A case series
- 1 June 2016
- Published by Elsevier in Arab Journal of Gastroenterology
- Vol. 17 (2) , 105-109
Haemophagocytic lymphohistiocytosis presenting as neonatal liver failure: A case series
- 20 October 2010
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 78 (3) , 301-306
Study of Predictive Value of Pediatric Risk of Mortality (PRISM) Score in Children with End Stage Liver Disease and Fulminant Hepatic Failure
To evaluate the use of the PRISM score as a predictor of outcome in patients with end stage liver disease (ESLD) and fulminant hepatic failure (FHF). The present study included 30 patients with ESLD and FHF, with ages ranging from 2 to 108 months, who were admitted to the Emergency room (ER) and the Pediatric Hepatology Unit at Cairo University Children’s Hospital (tertiary referral hospital) over a six-month-period from May through October 2008. Survivors were followed up for 6 months. Two other scores were also calculated, the PELD score and the Child-Pugh score. The outcome was defined as survivors and deceased. Deceased patients as compared with survivors were significantly younger (median age 7 vs. 24 months, p = 0.003). A ROC curve was constructed for the PRISM score, the predicted death rate (PDR) and the PELD score in the 30 patients. PRISM score was significantly associated with mortality (p = 0.04). The best cut off value was 9.5 (70.6% sensitive and 61% specific). PDR was also significantly associated with mortality (p = 0.011). The best cut off value for PDR was 5.95 (70.6% sensitive, 85% specific). On the other hand, the PELD score was not associated with mortality (p = 0.202). PRISM score can be applied with an adequate degree of accuracy for severity assessment and mortality prediction to pediatric patients with ESLD or FHF.
- 20 October 2010
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 78 (3) , 301-306
Study of Predictive Value of Pediatric Risk of Mortality (PRISM) Score in Children with End Stage Liver Disease and Fulminant Hepatic Failure
To evaluate the use of the PRISM score as a predictor of outcome in patients with end stage liver disease (ESLD) and fulminant hepatic failure (FHF). The present study included 30 patients with ESLD and FHF, with ages ranging from 2 to 108 months, who were admitted to the Emergency room (ER) and the Pediatric Hepatology Unit at Cairo University Children’s Hospital (tertiary referral hospital) over a six-month-period from May through October 2008. Survivors were followed up for 6 months. Two other scores were also calculated, the PELD score and the Child-Pugh score. The outcome was defined as survivors and deceased. Deceased patients as compared with survivors were significantly younger (median age 7 vs. 24 months, p = 0.003). A ROC curve was constructed for the PRISM score, the predicted death rate (PDR) and the PELD score in the 30 patients. PRISM score was significantly associated with mortality (p = 0.04). The best cut off value was 9.5 (70.6% sensitive and 61% specific). PDR was also significantly associated with mortality (p = 0.011). The best cut off value for PDR was 5.95 (70.6% sensitive, 85% specific). On the other hand, the PELD score was not associated with mortality (p = 0.202). PRISM score can be applied with an adequate degree of accuracy for severity assessment and mortality prediction to pediatric patients with ESLD or FHF.